Keystones in lymph node development

Journal of Anatomy

Volumn 209, Issue 5, 2006, Pages 585-595

  Blum, Katrin S ^a   Pabst, Reinhard ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Alymphoplasia; Lymph node development; Secondary lymphoid organs; Tertiary lymphoid organs

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR CCR7; CHEMOKINE RECEPTOR CXCR5; CXCL13 CHEMOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 7 RECEPTOR; INTERLEUKIN 7 RECEPTOR ALPHA; JANUS KINASE 3; LYMPHOTOXIN; LYMPHOTOXIN ALPHA1 BETA2; LYMPHOTOXIN BETA RECEPTOR; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MACROPHAGE INFLAMMATORY PROTEIN 2; MACROPHAGE INFLAMMATORY PROTEIN 3BETA; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; SECONDARY LYMPHOID TISSUE CHEMOKINE; STROMAL CELL DERIVED FACTOR 1; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1; VASCULOTROPIN C; VASCULOTROPIN RECEPTOR 3;

AUTOIMMUNE DISEASE; CELL ADHESION; CELL DIFFERENTIATION; CELL FUNCTION; CELL MATURATION; CELL MIGRATION; CHRONIC GRAFT REJECTION; COMBINED IMMUNODEFICIENCY; COMPARATIVE ANATOMY; EMBRYOLOGY; ENDOTHELIUM CELL; FETUS LIVER; GENE EXPRESSION; GENE MUTATION; GERMINAL CENTER; HEMATOPOIETIC STEM CELL; HUMAN; IMMUNE DEFICIENCY; IMMUNE RESPONSE; LYMPH NODE; LYMPHATIC SYSTEM; LYMPHOID ORGAN; LYMPHOID TISSUE; LYMPHOPOIESIS; NONHUMAN; PRIORITY JOURNAL; PSORIASIS; REVIEW; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; T LYMPHOCYTE; ULCERATIVE COLITIS;

ANIMALS; CELL DIFFERENTIATION; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; FETAL DEVELOPMENT; IMMUNE SYSTEM DISEASES; LIVER; LYMPH NODES; LYMPHOTOXIN BETA RECEPTOR; LYMPHOTOXIN-ALPHA; MICE; MODELS, ANIMAL;

EID: 33750352456     PISSN: 00218782     EISSN: 14697580     Source Type: Journal    
DOI: 10.1111/j.1469-7580.2006.00650.x     Document Type: Review

References (84)

1. Adachi S, Yoshida H, Honda K, et al. (1998) Essential role of IL-7 receptor α in the formation of Peyer's patch anlage. Int Immunol 10, 1-6.
2. Alimzhanov MB, Kuprash DV, Kosco-Vilbois MH, et al. (1997) Abnormal development of secondary lymphoid tissues in lymphotoxin β-deficient mice. Proc Natl Acad Sci USA 94, 9302-9307.
3. Aloisi F, Pujol-Borrell R (2006) Lymphoid neogenesis in chronic inflammatory diseases. Nat Rev Immunol 6, 205-217.
4. Ansel KM, Ngo VN, Hyman PL, et al. (2000) A chemokine-driven positive feedback loop organizes lymphoid follicles. Nature 406, 309-314.
5. Ansel KM, Cyster JG (2001) Chemokines in lymphopoiesis and lymphoid organ development. Curr Opin Immunol 13, 172-179.
6. Baddoura FK, Nasr IW, Wrobel B, et al. (2005) Lymphoid neogenesis in murine cardiac allografts undergoing chronic rejection. Am J Transplant 5, 510-516.
7. Banks TA, Rouse BT, Kerley MK, et al. (1995) Lymphotoxin-α-deficient mice. Effects on secondary lymphoid organ development and humoral immune responsiveness. J Immunol 155, 1685-1693.
8. Berry CL (1970) Histopathological findings in the combined immunity-deficiency syndrome. J Clin Pathol 23, 193-202.
9. Bonilla FA, Bernstein IL, Khan DA, et al. (2005) Practice parameter for the diagnosis and management of primary immunodeficiency. Ann Allergy Asthma Immunol 94, S1-S63.
10. Browning JL, French LE (2002) Visualization of lymphotoxin-β and lymphotoxin-β receptor expression in mouse embryos. J Immunol 168, 5079-5087.
11. Buckley RH (2004) Molecular defects in human severe combined immunodeficiency and approaches to immune reconstitution. Annu Rev Immunol 22, 625-655.
12. Candotti F, Notarangelo L, Visconti R, O'Shea J (2002) Molecular aspects of primary immunodeficiencies: Lessons from cytokine and other signaling pathways. J Clin Invest 109, 1261-1269.
13. Chen SC, Leach MW, Chen Y, et al. (2002a) Central nervous system inflammation and neurological disease in transgenic mice expressing the CC chemokine CCL21 in oligodendrocytes. J Immunol 168, 1009-1017.
14. Chen SC, Vassileva G, Kinsley D, et al. (2002b) Ectopic expression of the murine chemokines CCL21a and CCL21b induces the formation of lymph node-like structures in pancreas, but not skin, of transgenic mice. J Immunol 168, 1001-1008.
15. Cunningham-Rundles C, Ponda PP (2005) Molecular defects in T- and B-cell primary immunodeficiency diseases. Nat Rev Immunol 5, 880-892.
16. Cupedo T, Mebius RE (2003) Role of chemokines in the development of secondary and tertiary lymphoid tissues. Semin Immunol 15, 243-248.
17. Cupedo T, Jansen W, Kraal G, Mebius RE (2004a) Induction of secondary and tertiary lymphoid structures in the skin. Immunity 21, 655-667.
18. Cupedo T, Vondenhoff MF, Heeregrave EJ, et al. (2004b) Presumptive lymph node organizers are differentially represented in developing mesenteric and peripheral nodes. J Immunol 173, 2968-2975.
19. De Togni P, Goellner J, Ruddle NH, et al. (1994) Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin. Science 264, 703-707.
20. Dejardin E, Droin NM, Delhase M, et al. (2002) The lymphotoxin-β receptor induces different patterns of gene expression via two NF-κβ pathways. Immunity 17, 525-535.
21. Drayton DL, Ying X, Lee J, Lesslauer W, Ruddle NH (2003) Ectopic LT αβ directs lymphoid organ neogenesis with concomitant expression of peripheral node addressin and a HEV-restricted sulfotransferase. J Exp Med 197, 1153-1163.
22. Drayton DL, Liao S, Mounzer RH, Ruddle NH (2006) Lymphoid organ development: From ontogeny to neogenesis. Nat Immunol 7, 344-353.
23. Eberl G, Littman DR (2003) The role of the nuclear hormone receptor RORγt in the development of lymph nodes and Peyer's patches. Immunol Rev 195, 81-90.
24. Eberl G, Marmon S, Sunshine MJ, et al. (2004) An essential function for the nuclear receptor RORγ (t) in the generation of fetal lymphoid tissue inducer cells. Nat Immunol 5, 64-73.
25. Eberl G (2005) Inducible lymphoid tissues in the adult gut: recapitulation of a fetal developmental pathway? Nat Rev Immunol 5, 413-420.
26. Fan L, Reilly CR, Luo Y, Dorf ME, Lo D (2000) Cutting edge: Ectopic expression of the chemokine TCA4/SLC is sufficient to trigger lymphoid neogenesis. J Immunol 164, 3955-3959.
27. Finke D, Acha-Orbea H, Mattis A, Lipp M, Kraehenbuhl J (2002) CD4+ CD3-cells induce Peyer's patch development: Role of α4β1 integrin activation by CXCR5. Immunity 17, 363-373.
28. Forster R, Mattis AE, Kremmer E, et al. (1996) A putative chemokine receptor, BLR1, directs B cell migration to defined lymphoid organs and specific anatomic compartments of the spleen. Cell 87, 1037-1047.
29. Fukuyama S, Hiroi T, Yokota Y, et al. (2002) Initiation of NALT organogenesis is independent of the IL-7R, LTβR, and NIK signaling pathways but requires the Id2 gene and CD3 (-) CD4 (+) CD45 (+) cells. Immunity 17, 31-40.
30. Futterer A, Mink K, Luz A, Kosco-Vilbois MH, Pfeffer K (1998) The lymphotoxin β receptor controls organogenesis and affinity maturation in peripheral lymphoid tissues. Immunity 9, 59-70.
31. Gramaglia I, Mauri DN, Miner KT, Ware CF, Croft M (1999) Lymphotoxin αβ is expressed on recently activated naive and Th1-like CD4 cells but is down-regulated by IL-4 during Th2 differentiation. J Immunol 162, 1333-1338.
32. Grant AJ, Goddard S, Ahmed-Choudhury J, et al. (2002) Hepatic expression of secondary lymphoid chemokine (CCL21) promotes the development of portal-associated lymphoid tissue in chronic inflammatory liver disease. Am J Pathol 160, 1445-1455.
33. Honda K, Nakano H, Yoshida H, et al. (2001) Molecular basis for hematopoietic/mesenchymal interaction during initiation of Peyer's patch organogenesis. J Exp Med 193, 621-630.
34. Hong YK, Harvey N, Noh YH, et al. (2002) Prox1 is a master control gene in the program specifying lymphatic endothelial cell fate. Dev Dyn 225, 351-357.
35. Jackson DG, Prevo R, Clasper S, Banerji S (2001) LYVE-1, the lymphatic system and tumor lymphangiogenesis. Trends Immunol 22, 317-321.
36. Karkkainen MJ, Haiko P, Sainio K, et al. (2004) Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins. Nat Immunol 5, 74-80.
37. Kenny AB, Hitzig WH (1979) Bone marrow transplantation for severe combined immunodeficiency disease. Reported from 1968 to 1977. Eur J Pediatr 131, 155-177.
38. Kerjaschki D, Regele HM, Moosberger I, et al. (2004) Lymphatic neoangiogenesis in human kidney transplants is associated with immunologically active lymphocytic infiltrates. J Am Soc Nephrol 15, 603-612.
39. Kerjaschki D, Huttary N, Raab I, et al. (2006) Lymphatic endothelial progenitor cells contribute to de novo lymphangiogenesis in human renal transplants. Nat Med 12, 230-234.
40. Kim D, Mebius RE, MacMicking JD, et al. (2000) Regulation of peripheral lymph node genesis by the tumor necrosis factor family member TRANCE. J Exp Med 192, 1467-1478.
41. Kong YY, Yoshida H, Sarosi I, et al. (1999) OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 397, 315-323.
42. Koni PA, Sacca R, Lawton P, et al. (1997) Distinct roles in lymphoid organogenesis for lymphotoxins α and β revealed in lymphotoxin β-deficient mice. Immunity 6, 491-500.
43. Kratz A, Campos-Neto A, Hanson MS, Ruddle NH (1996) Chronic inflammation caused by lymphotoxin is lymphoid neogenesis. J Exp Med 183, 1461-1472.
44. Kukk E, Lymboussaki A, Taira S, et al. (1996) VEGF-C receptor binding and pattern of expression with VEGFR-3 suggests a role in lymphatic vascular development. Development 122, 3829-3837.
45. Kurebayashi S, Ueda E, Sakaue M, et al. (2000) Retinoid-related orphan receptor γ (RORγ) is essential for lymphoid organogenesis and controls apoptosis during thymopoiesis. Proc Natl Acad Sci USA 97, 10132-10137.
46. Luther SA, Lopez T, Bai W, Hanahan D, Cyster JG (2000) BLC expression in pancreatic islets causes B cell recruitment and lymphotoxin-dependent lymphoid neogenesis. Immunity 12, 471-481.
47. Luther SA, Bidgol A, Hargreaves DC, et al. (2002) Differing activities of homeostatic chemokines CCL19, CCL21, and CXCL12 in lymphocyte and dendritic cell recruitment and lymphoid neogenesis. J Immunol 169, 424-433.
48. Luther SA, Ansel KM, Cyster JG (2003) Overlapping roles of CXCL13, interleukin 7 receptor α, and CCR7 ligands in lymph node development. J Exp Med 197, 1191-1198.
49. Manzo A, Paoletti S, Carulli M, et al. (2005) Systematic microanatomical analysis of CXCL13 and CCL21 in situ production and progressive lymphoid organization in rheumatoid synovitis. Eur J Immunol 35, 1347-1359.
50. Matsui J, Wakabayashi T, Asada M, Yoshimatsu K, Okada M (2004) Stem cell factor/c-kit signaling promotes the survival, migration, and capillary tube formation of human umbilical vein endothelial cells. J Biol Chem 279, 18600-18607.
51. Mauri DN, Ebner R, Montgomery RI, et al. (1998) LIGHT, a new member of the TNF superfamily, and lymphotoxin α are ligands for herpesvirus entry mediator. Immunity 8, 21-30.
52. Mebius RE, Rennert P, Weissman IL (1997) Developing lymph nodes collect CD4+CD3-LTβ+ cells that can differentiate to APC, NK cells, and follicular cells but not T or B cells. Immunity 7, 493-504.
53. Muller G, Hopken UE, Lipp M (2003) The impact of CCR7 and CXCR5 on lymphoid organ development and systemic immunity. Immunol Rev 195, 117-135.
54. Ohl L, Henning G, Krautwald S, et al. (2003) Cooperating mechanisms of CXCR5 and CCR7 in development and organization of secondary lymphoid organs. J Exp Med 197, 1199-1204.
55. Ohshima Y, Yang LP, Avice MN, et al. (1999) Naive human CD4+ T cells are a major source of lymphotoxin α. J Immunol 162, 3790-3794.
56. Okada S, Nakauchi H, Nagayoshi K, et al. (1992) In vivo and in vitro stem cell function of c-kit- and Sca-1-positive murine hematopoietic cells. Blood 80, 3044-3050.
57. Oliver G (2004) Lymphatic vasculature development. Nat Rev Immunol 4, 35-45.
58. Oliver G, Alitalo K (2005) The lymphatic vasculature: Recent progress and paradigms. Annu Rev Cell Dev Biol 21, 457-483.
59. Pabst R (2004) Lymphknoten. In Anatomie, Makroskopische Anatomie, Histologie, Embryologie, Zellbiologie, Vol. 2 (ed. Drenckhahn D), pp. 156-159. München: Elsevier, Urban und Fischer.
60. Petrova TV, Makinen T, Makela TP, et al. (2002) Lymphatic endothelial reprogramming of vascular endothelial cells by the Prox-1 homeobox transcription factor. EMBO J 21, 4593-4599.
61. Picker LJ, Butcher EC (1992) Physiological and molecular mechanisms of lymphocyte homing. Annu Rev Immunol 10, 561-591.
62. Rennert PD, Browning JL, Mebius R, Mackay F, Hochman PS (1996) Surface lymphotoxin α/β complex is required for the development of peripheral lymphoid organs. J Exp Med 184, 1999-2006.
63. Roifman CM, Zhang J, Chitayat D, Sharfe N (2000) A partial deficiency of interleukin-7R α is sufficient to abrogate T-cell development and cause severe combined immunodeficiency. Blood 96, 2803-2807.
64. Rosen FS, Cooper MD, Wedgwood RJ (1995) The primary immunodeficiencies. N Engl J Med 333, 431-440.
65. Ruddle NH (1999) Lymphoid neo-organogenesis: Lymphotoxin's role in inflammation and development. Immunol Res 19, 119-125.
66. Russell SM, Tayebi N, Nakajima H, et al. (1995) Mutation of Jak3 in a patient with SCID: Essential role of Jak3 in lymphoid development. Science 270, 797-800.
67. Salomonsson S, Larsson P, Tengner P, et al. (2002) Expression of the B cell-attracting chemokine CXCL13 in the target organ and autoantibody production in ectopic lymphoid tissue in the chronic inflammatory disease Sjogren's syndrome. Scand J Immunol 55, 336-342.
68. Scheu S, Alferink J, Potzel T, et al. (2002) Targeted disruption of LIGHT causes defects in costimulatory T cell activation and reveals cooperation with lymphotoxin β in mesenteric lymph node genesis. J Exp Med 195, 1613-1624.
69. Schneider M, Othman-Hassan K, Christ B, Wilting J (1999) Lymphangioblasts in the avian wing bud. Dev Dyn 216, 311-319.
70. Schneider K, Potter KG, Ware CF (2004) Lymphotoxin and LIGHT signaling pathways and target genes. Immunol Rev 202, 49-66.
71. Spangrude GJ, Brooks DM (1993) Mouse strain variability in the expression of the hematopoietic stem cell antigen Ly-6A/E by bone marrow cells. Blood 82, 3327-3332.
72. Sun Z, Unutmaz D, Zou YR, et al. (2000) Requirement for RORγ in thymocyte survival and lymphoid organ development. Science 288, 2369-2373.
73. Suzuki H, Watabe T, Kato M, Miyazawa K, Miyazono K (2005) Roles of vascular endothelial growth factor receptor 3 signaling in differentiation of mouse embryonic stem cell-derived vascular progenitor cells into endothelial cells. Blood 105, 2372-2379.
74. Thaunat O, Field AC, Dai J, et al. (2005) Lymphoid neogenesis in chronic rejection: Evidence for a local humoral alloimmune response. Proc Natl Acad Sci USA 102, 14723-14728.
75. Wang JH, Nichogiannopoulou A, Wu L, et al. (1996) Selective defects in the development of the fetal and adult lymphoid system in mice with an Ikaros null mutation. Immunity 5, 537-549.
76. Wang J, Foster A, Chin R, et al. (2002) The complementation of lymphotoxin deficiency with LIGHT, a newly discovered TNF family member, for the restoration of secondary lymphoid structure and function. Eur J Immunol 32, 1969-1979.
77. Wang Y, Subudhi SK, Anders RA, et al. (2005) The role of herpesvirus entry mediator as a negative regulator of T cell-mediated responses. J Clin Invest 115, 711-717.
78. Weih F, Caamano J (2003) Regulation of secondary lymphoid organ development by the nuclear factor-êB signal transduction pathway. Immunol Rev 195, 91-105.
79. Weninger W, Carlsen HS, Goodarzi M, et al. (2003) Naive T cell recruitment to nonlymphoid tissues: A role for endothelium-expressed CC chemokine ligand 21 in autoimmune disease and lymphoid neogenesis. J Immunol 170, 4638-4648.
80. Wigle JT, Oliver G (1999) Prox1 function is required for the development of the murine lymphatic system. Cell 98, 769-778.
81. Wigle JT, Harvey N, Detmar M, et al. (2002) An essential role for Prox1 in the induction of the lymphatic endothelial cell phenotype. EMBO J 21, 1505-1513.
82. Wu L, Nichogiannopoulou A, Shortman K, Georgopoulos K (1997) Cell-autonomous defects in dendritic cell populations of Ikaros mutant mice point to a developmental relationship with the lymphoid lineage. Immunity 7, 483-492.
83. Yokota Y, Mansouri A, Mori S, et al. (1999) Development of peripheral lymphoid organs and natural killer cells depends on the helix-loop-helix inhibitor Id2. Nature 397, 702-706.
84. Yoshida H, Naito A, Inoue J, et al. (2002) Different cytokines induce surface lymphotoxin-αβ on IL-7 receptor-α cells that differentially engender lymph nodes and Peyer's patches. Immunity 17, 823-833.